Mouse Anti-CRYM Recombinant Antibody (CBFYC-2257) (V2LY-1206-LY1337)

Kinney, C. J., & Bloch, R. J. (2021). µ-Crystallin: A thyroid hormone binding protein. Endocrine Regulations, 55(2), 89-102.

Jank, B. J., Haas, M., Schnoell, J., Schlederer, M., Heiduschka, G., Kenner, L., & Kadletz-Wanke, L. (2021). µ-Crystallin Is Associated with Disease Outcome in Head and Neck Squamous Cell Carcinoma. Journal of Personalized Medicine, 11(12), 1330.

Kinney, C. J., O'Neill, A., Noland, K., Huang, W., Muriel, J., Lukyanenko, V., ... & Bloch, R. J. (2021). μ-Crystallin in mouse skeletal muscle promotes a shift from glycolytic toward oxidative metabolism. Current research in physiology, 4, 47-59.

Wang, M., Li, Q., Deng, A., Zhu, X., & Yang, J. (2020). Identification of a novel mutation in CRYM in a Chinese family with hearing loss using whole‑exome sequencing. Experimental and therapeutic medicine, 20(2), 1447-1454.

Ohkubo, Y., Sekido, T., Nishio, S. I., Sekido, K., Kitahara, J., Suzuki, S., & Komatsu, M. (2019). Loss of μ-crystallin causes PPARγ activation and obesity in high-fat diet-fed mice. Biochemical and biophysical research communications, 508(3), 914-920.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols